Skip to main content

Table 2 Demographics of Autism and ASD Participants

From: Vitamin/mineral/micronutrient supplement for autism spectrum disorders: a research survey

Gender

 Male

138 (86%)

 Female

23 (14%)

Age

12.7 ± 9.1 years (1–74 years)

Age Distribution

 1–5 years

27 (17%)

 5–10 years

53 (33%)

 11–15 years

32 (20%)

 16–20 years

31 (19%)

 21–25 years

6 (4%)

 26–30 years

4 (2%)

 31 + years

7 (4%)

Person completing the questionnaire

 Parent/Guardian

153 (95%)

 Grandparent

2 (1%)

 Self

6 (4%)

Diagnosis

 Autism

84 (52%)

 ASD

77 (48%)

Country of Residence

 United States

153 (95%)

 Non-US

8 (5%)

Race

 White/Caucasian

103 (64%)

 African American/Black

6 (4%)

 Asian Indian

14 (9%)

 Asian non-Indian

17 (11%)

 Other

21 (13%)

Ethnicity

 Hispanic

17 (11%)

 Non-Hispanic

141(88%)

 unspecified

3 (2%)

Autism severity

 Mild

39 (24%)

 Moderate

76 (47%)

 Severe

45 (28%)

Developmental History of Autism

 Early onset

82 (51%)

 Normal development, followed by regression or plateau

79 (49%)

 Age at regression/plateau

20 ± 11 months

Seizures

10 (6%)

Intellectual Disability

31 (19%)

Asthma

7 (4%)

Use of Psychiatric or Seizure Medications

65 (39%)

Duration of usage of ANRC-EP

 3–5 months

47

 6–8 months

15

 9–12 months

21

 1–2 years

35

 2–3 years

24

 4 + years

19